Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) Boston, Massachusetts March 4-7, 2018 Back

MULTIPLE DAILY DOSES OF MK-8591 AS LOW AS 0.25 MG ARE EXPECTED TO SUPPRESS HIV       Reported by Jules Levin CROI 2018 March 4-7 Boston, MA   Randolph P. Matthews, Deanne J. Rudd, Vanessa Levine, Sandra Zhang, Laura Sterling, Jay Grobler, Ryan Vargo, S. Aubrey Stoch, Marian Iwamoto   WEBCAST: http://www.croiwebcasts.org/console/player/37063?mediaType=slideVideo&&crd_fl=1&ssmsrq=1522781323018&ctms=5000&csmsrq=890